Regulus Therapeutics
RGLS
#6955
Rank
NZ$0.98 B
Marketcap
NZ$14.16
Share price
0.00%
Change (1 day)
423.36%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: NZ$0.98 Billion

As of December 2025 Regulus Therapeutics has a market cap of NZ$0.98 Billion. This makes Regulus Therapeutics the world's 6955th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$0.98 B448.19%
2024NZ$0.17 B336.97%
2023NZ$40.93 M12.64%
2022NZ$36.33 M-46.02%
2021NZ$67.31 M-43.34%
2020NZ$0.11 B327.77%
2019NZ$27.77 M127.05%
2018NZ$12.23 M-91.96%
2017NZ$0.15 B-11.45%
2016NZ$0.17 B-74.38%
2015NZ$0.67 B-33.03%
2014NZ$1.00 B166.64%
2013NZ$0.37 B36.94%
2012NZ$0.27 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
GlaxoSmithKline
GSK
NZ$170.86 B 17,326.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
NZ$203.29 B 20,634.55%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$43.25 B 4,312.10%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$487.57 B 49,628.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
NZ$90.80 B 9,161.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$0.25 B-74.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$188.41 B 19,117.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
NZ$5.16 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA